Mark Einstein

Medicine & Life Sciences

1. Uterine Cervical Neoplasms 100%
2. Cervical Intraepithelial Neoplasia 50%
3. Colposcopy 49%
4. Early Detection of Cancer 39%
5. Human papillomavirus 16 35%
6. Neoplasms 31%
7. Squamous Intraepithelial Lesions 30%
8. Papillomavirus Infections 29%
9. HIV 29%
10. Anus Neoplasms 27%
11. Human papillomavirus 18 25%
12. Cell Biology 25%
13. Papillomavirus Vaccines 23%
14. Vaccines 23%
15. Endometrial Neoplasms 23%
16. Safety 19%
17. Vaccination 19%
18. Guidelines 17%
19. Human papillomavirus 11 15%
20. Atypical Squamous Cells of the Cervix 14%
21. Human papillomavirus 6 14%
22. Survival 14%
23. Genitalia 13%
24. Ovarian Neoplasms 12%
25. Paclitaxel 12%
26. Therapeutics 12%
27. Papillomaviridae 12%
28. Pathology 12%
29. Cisplatin 11%
30. Foams and Jellies Vaginal Creams 11%
31. Radiation 10%
32. DNA 10%
33. Acquired Immunodeficiency Syndrome 9%
34. Radiotherapy 9%
35. Clinical Trials 9%
36. Carcinogenesis 9%
37. Triage 8%
38. 5-aminolevulinic acid hexyl ester 8%
39. Carboplatin 8%
40. Immunotherapy 8%
41. Belize 8%
42. Docetaxel 8%
43. Population 8%
44. Placebos 7%
45. Carcinosarcoma 7%
46. Biopsy 7%
47. Drug Therapy 7%
48. Antibodies 7%
49. Uterine Neoplasms 7%
50. Infections 7%